|
Volumn 355, Issue 2, 2006, Pages 207-209
|
Homocysteine, B vitamins, and cardiovascular disease [8]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYANOCOBALAMIN;
FOLIC ACID;
HOMOCYSTEINE;
PLACEBO;
PYRIDOXINE;
VITAMIN B GROUP;
VITAMIN B COMPLEX;
AMINO ACID METABOLISM;
ANALYTICAL ERROR;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
CORONARY ARTERY BYPASS SURGERY;
CYANOCOBALAMIN DEFICIENCY;
DOSE RESPONSE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG FORMULATION;
FACTORIAL DESIGN;
GENETIC SUSCEPTIBILITY;
HUMAN;
HYPERHOMOCYSTEINEMIA;
LETTER;
MEDICAL EXAMINATION;
MEDICAL RESEARCH;
MULTIVARIATE ANALYSIS;
PERCUTANEOUS CORONARY INTERVENTION;
PRIORITY JOURNAL;
STROKE;
TREATMENT OUTCOME;
UNSPECIFIED SIDE EFFECT;
NOTE;
STATISTICAL ANALYSIS;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS;
DATA INTERPRETATION, STATISTICAL;
FOLIC ACID;
HUMANS;
HYPERHOMOCYSTEINEMIA;
VITAMIN B 12;
VITAMIN B 6;
VITAMIN B COMPLEX;
|
EID: 33745918010
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (7)
|
References (2)
|